The NHS cervical screening programme audit of invasive cervical cancers: who benefits?

BJOG

Pan-Birmingham Gynaecological Cancer Centre, City Hospital, West Midlands Cervical Screening QA Reference Centre, University of Birmingham, Birmingham, UK.

Published: January 2012

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-0528.2011.03144.xDOI Listing

Publication Analysis

Top Keywords

nhs cervical
4
cervical screening
4
screening programme
4
programme audit
4
audit invasive
4
invasive cervical
4
cervical cancers
4
cancers benefits?
4
nhs
1
screening
1

Similar Publications

Natural History and Long Term Follow-Up of Incidental Thyroid Nodules on Computed Tomography Imaging.

Br J Radiol

January 2025

Consultant Head and Neck Radiologist, Department of Radiology, Glasgow Royal Infirmary, Glasgow, United Kingdom.

Objectives: incidental thyroid nodules (ITNs) are found in up to 25% of CT scans. Increased use of cross-sectional imaging has contributed to the increased incidence of thyroid cancer worldwide. ITNs pose a management dilemma since nodule malignancy rate is 5-15% but most cancers are indolent and prognosis in differentiated thyroid cancer is excellent.

View Article and Find Full Text PDF

A Pilot Study of the Anthropometric Growth Pattern of the Human Auricle of the North Indian Region.

Cureus

December 2024

Department of Otolaryngology, Head and Neck Surgery, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, GBR.

Objectives To assess the dimensions of external ear (pinna) in different age groups in the North Indian population. To assess the mean dimensions of external ear (pinna) in different age groups in North Indian males and females. Methods The study area was Lucknow/Barabanki, Uttar Pradesh, and the study center was Era's Lucknow Medical College, Uttar Pradesh, India.

View Article and Find Full Text PDF

Introduction: Despite repeated vaccinations against SARS-CoV-2 virus, patients who are immunocompromised remain at very high risk of catching SARS-CoV-2 virus and becoming unwell. AZD7442 (Evusheld) is a long-acting monoclonal antibody treatment that has been shown in clinical trials to prevent SARS-CoV-2 infection for up to a year after a single dose. Vaccines require a healthy immune system to generate protective immunity.

View Article and Find Full Text PDF

Background: This study examines the management and outcomes of large paranasal sinus osteomas (PSO), especially those abutting or encasing critical structures of the skull base and orbit.

Methodology: A multicentric retrospective analysis was conducted between June 2007 and September 2023. The study included surgically treated (regardless the type of approach chosen) PSO, exceeding 3 cm in diameter and/or located in critical anatomical areas.

View Article and Find Full Text PDF

A woman in her 30s presented with sudden onset right-sided weakness, speech difficulties and transient loss of consciousness. She had a medical history of migraine, hypothyroidism and cervical lymphadenopathy. On examination, her National Institutes of Health Stroke Scale (NIHSS) score was 8 due to dense right-sided hemiparesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!